James Edgemond - 04 Nov 2025 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Reporting relationship: CFO AND TREASURER
Issuer ticker: UTHR
Reported as of: 04 Nov 2025
Net transaction value: -$6,091,191
SEC form: 4
Accepted by SEC: 05 Nov 2025, 16:31:13 UTC
Prior SEC filing: 10 Jun 2025
Next SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ John S. Hess, Jr. under Power of Attorney

Key filing fact

James Edgemond filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 05 Nov 2025.

Key facts

This page summarizes James Edgemond's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
11 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Nov 2025, 16:31.

Change

Previous filing in this sequence was filed on 10 Jun 2025.
Current net transaction value: -$6,091,191.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001636178 Primary reporting owner

EDGEMOND JAMES

Relationship: CFO AND TREASURER
Address: C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
Signature: /s/ John S. Hess, Jr. under Power of Attorney
Signature date: 05 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTHR transaction

Common Stock

Options Exercise

Transaction value: $3,066,630
Shares: +21,000
Change %: +259%
Price: $146.03
Shares after: 29,118
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1

UTHR transaction

Common Stock

Sale

Transaction value: $42,345
Shares: -98
Change %: -0.34%
Price: $432.09
Shares after: 29,020
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F2

UTHR transaction

Common Stock

Sale

Transaction value: $464,892
Shares: -1,074
Change %: -3.7%
Price: $432.86
Shares after: 27,946
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F3

UTHR transaction

Common Stock

Sale

Transaction value: $655,872
Shares: -1,512
Change %: -5.4%
Price: $433.78
Shares after: 26,434
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F4

UTHR transaction

Common Stock

Sale

Transaction value: $730,302
Shares: -1,679
Change %: -6.4%
Price: $434.96
Shares after: 24,755
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F5

UTHR transaction

Common Stock

Sale

Transaction value: $2,653,239
Shares: -6,088
Change %: -25%
Price: $435.81
Shares after: 18,667
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F6

UTHR transaction

Common Stock

Sale

Transaction value: $3,195,910
Shares: -7,317
Change %: -39%
Price: $436.78
Shares after: 11,350
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F7

UTHR transaction

Common Stock

Sale

Transaction value: $1,204,662
Shares: -2,752
Change %: -24%
Price: $437.74
Shares after: 8,598
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F8

UTHR transaction

Common Stock

Sale

Transaction value: $157,859
Shares: -360
Change %: -4.2%
Price: $438.50
Shares after: 8,238
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F9

UTHR transaction

Common Stock

Sale

Transaction value: $52,741
Shares: -120
Change %: -1.5%
Price: $439.51
Shares after: 8,118
Date: 04 Nov 2025
Ownership: Direct
Footnotes: F1, F10

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTHR transaction Derivative

Stock Options

Options Exercise

Transaction value: $0
Shares: -21,000
Change %: -40%
Price: $0.000000
Shares after: 31,312
Date: 04 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,000
Exercise price: $146.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.

Footnote F10

This transaction was executed in multiple trades at prices ranging from $439.37 to $439.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $431.31 to $432.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $432.31 to $433.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

This transaction was executed in multiple trades at prices ranging from $433.31 to $434.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F5

This transaction was executed in multiple trades at prices ranging from $434.31 to $435.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F6

This transaction was executed in multiple trades at prices ranging from $435.31 to $436.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F7

This transaction was executed in multiple trades at prices ranging from $436.31 to $437.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F8

This transaction was executed in multiple trades at prices ranging from $437.31 to $438.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F9

This transaction was executed in multiple trades at prices ranging from $438.34 to $438.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.